Sotera Health Company (NASDAQ:SHC) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Sotera Health Company (NASDAQ:SHC) has received a consensus recommendation of “Moderate Buy” from the eleven brokerages that are presently covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $20.2857.

Several equities research analysts recently issued reports on the stock. Weiss Ratings cut shares of Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a research report on Thursday, May 21st. Wall Street Zen cut shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, April 11th. Barclays cut their price objective on shares of Sotera Health from $20.00 to $18.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. Piper Sandler restated an “overweight” rating and set a $22.00 price objective (down from $24.00) on shares of Sotera Health in a research report on Wednesday, May 6th. Finally, Citigroup boosted their price target on shares of Sotera Health from $21.00 to $23.00 and gave the company a “buy” rating in a research note on Tuesday, February 24th.

Insider Activity

In other news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the business’s stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total value of $193,194,516.17. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 15.36% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in SHC. Empowered Funds LLC grew its holdings in shares of Sotera Health by 11.1% in the first quarter. Empowered Funds LLC now owns 28,512 shares of the company’s stock valued at $332,000 after purchasing an additional 2,845 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Sotera Health by 14.5% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 342,934 shares of the company’s stock valued at $3,999,000 after purchasing an additional 43,471 shares in the last quarter. Acadian Asset Management LLC grew its holdings in shares of Sotera Health by 125.5% in the first quarter. Acadian Asset Management LLC now owns 25,192 shares of the company’s stock valued at $293,000 after purchasing an additional 14,018 shares in the last quarter. Creative Planning grew its holdings in Sotera Health by 15.3% during the 2nd quarter. Creative Planning now owns 20,186 shares of the company’s stock worth $224,000 after acquiring an additional 2,673 shares in the last quarter. Finally, Invesco Ltd. grew its holdings in Sotera Health by 4.2% during the 2nd quarter. Invesco Ltd. now owns 319,156 shares of the company’s stock worth $3,549,000 after acquiring an additional 12,758 shares in the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

Sotera Health Stock Performance

NASDAQ:SHC opened at $16.04 on Wednesday. The company’s 50-day moving average price is $15.66 and its 200-day moving average price is $16.36. The company has a current ratio of 2.82, a quick ratio of 2.54 and a debt-to-equity ratio of 3.56. The company has a market cap of $4.57 billion, a P/E ratio of 39.12 and a beta of 1.79. Sotera Health has a twelve month low of $10.80 and a twelve month high of $19.85.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.01. The firm had revenue of $280.05 million for the quarter, compared to the consensus estimate of $270.78 million. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The company’s revenue for the quarter was up 10.0% on a year-over-year basis. During the same period last year, the firm posted $0.14 earnings per share. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. On average, sell-side analysts forecast that Sotera Health will post 0.86 earnings per share for the current fiscal year.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.